Literature DB >> 20951014

Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.

M Agueda1, A Lasa, E Simon, R Ares, E Larrarte, I Labayen.   

Abstract

BACKGROUND AND AIMS: To assess the influence of body composition changes on circulating serum visfatin after following 12 weeks of energy restricted diet intervention. We also examined the possible role of visfatin in glucose metabolism and in obesity-associated low-grade inflammation. METHODS AND
RESULTS: A total of 78 obese (BMI 34.0 ± 2.8 kg/m²) women aged 36.7±7 y volunteered to participate in the study. We measured by DXA body fat mass (FM) and lean mass (LM). Fasting serum visfatin, glucose, insulin, adiponectin, leptin, IL-1β, IL-6, IL-8, TNF-α and CRP concentrations were analyzed before and after the intervention and HOMA and QUIKI indexes were calculated. Mean weight loss 7.7 ± 3.0 kg and HOMA decreased in 24 ± 35%. Serum visfatin concentration change was negatively associated with LM difference (P < 0.05), whereas no significant relationship was observed with FM changes after energy restricted diet intervention. Changes in circulating serum visfatin levels were significantly and inversely associated with HOMA-IR (P < 0.01) and positively with QUICKI index (P < 0.02) after energy restricted diet intervention, regardless of achieved body weight loss. We did not find any significant association between changes in visfatin levels and IL-1β, IL-6, IL-8, TNF-α and CRP levels after dietary intervention (all P > 0.2).
CONCLUSION: Circulating visfatin concentration is associated with sensitivity improvement achieved after energy restricted diet intervention induced weight loss. Furthermore, LM changes could be an influencing factor on visfatin concentrations and consequently, on the improvement of insulin sensitivity after weight loss in obese non-diabetic women. Our findings did not provide any evidence for a role of visfatin increase on low-grade inflammation after weight loss. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20951014     DOI: 10.1016/j.numecd.2010.06.010

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  5 in total

1.  Evidence in obese children: contribution of hyperlipidemia, obesity-inflammation, and insulin sensitivity.

Authors:  Chi-Jen Chang; Deng-Yuan Jian; Ming-Wei Lin; Jun-Zhi Zhao; Low-Tone Ho; Chi-Chang Juan
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

2.  Effects of dietary restriction on adipose mass and biomarkers of healthy aging in human.

Authors:  Daniele Lettieri-Barbato; Esmeralda Giovannetti; Katia Aquilano
Journal:  Aging (Albany NY)       Date:  2016-11-29       Impact factor: 5.682

3.  Variations in the PBEF1 gene are associated with body mass index: A population-based study in northern China.

Authors:  Jiesheng Rong; Minjie Chu; Baifen Xing; Lin Zhu; Shengyu Wang; Tianzun Tao; Yashuang Zhao; Liying Jiang
Journal:  Meta Gene       Date:  2015-09-21

4.  Data Independent Acquisition Mass Spectrometry Can Identify Circulating Proteins That Predict Future Weight Loss with a Diet and Exercise Programme.

Authors:  Nagaraj Malipatil; Helene A Fachim; Kirk Siddals; Bethany Geary; Gwen Wark; Nick Porter; Simon Anderson; Rachelle Donn; Michelle Harvie; Anthony D Whetton; Martin J Gibson; Adrian Heald
Journal:  J Clin Med       Date:  2019-01-25       Impact factor: 4.241

5.  Hyperleptinemia is associated with parameters of low-grade systemic inflammation and metabolic dysfunction in obese human beings.

Authors:  Sonia Leon-Cabrera; Lourdes Solís-Lozano; Karina Suárez-Álvarez; Antonio González-Chávez; Yadira L Béjar; Guillermo Robles-Díaz; Galileo Escobedo
Journal:  Front Integr Neurosci       Date:  2013-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.